logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Erosive Gastroesophageal Reflux Disease

    Medications for Erosive Gastroesophageal Reflux Disease

    FiltersReset Filters
    4 results

    • aciphex

      (rabeprazole sodium)
      Waylis Therapeutics LLC
      Usage: ACIPHEX is indicated for the healing and symptomatic relief of erosive or ulcerative GERD, maintenance of GERD healing, treatment of symptomatic GERD, healing of duodenal ulcers, eradication of Helicobacter pylori to reduce duodenal ulcer recurrence, long-term treatment of pathological hypersecretory conditions, and treatment in adolescents aged 12 and older.

    • famotidine

      (Famotidine)
      Lupin Pharmaceuticals, Inc.
      Usage: Famotidine for oral suspension is indicated for adults to treat active duodenal and gastric ulcers, symptomatic nonerosive GERD, erosive esophagitis due to GERD, pathological hypersecretory conditions, and to reduce duodenal ulcer recurrence. In pediatric patients, it treats peptic ulcer disease and GERD, including infants.

    • rabeprazole sodium

      (Rabeprazole Sodium)
      Chartwell RX, LLC
      Usage: Rabeprazole Sodium Delayed-Release Tablets are indicated for the healing and maintenance of erosive or ulcerative GERD, treatment of symptomatic GERD in adults and adolescents, healing of duodenal ulcers, H. pylori eradication, and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.

    • rabeprazole sodium

      (rabeprazole sodium)
      Advagen Pharma Limited
      Usage: Rabeprazole Sodium is indicated for the short-term treatment of erosive or ulcerative GERD, maintenance of healing, symptomatic GERD, healing of duodenal ulcers, H. pylori eradication, treatment of pathological hypersecretory conditions, and symptomatic GERD in adolescents aged 12 and older.